 |
concrete clinical goals have to be defined - at best supported by a scientific rationale
based on underlying molecular-biological mechanisms,
|
 |
the physiologic conditions for optimum absorption of the active drug ingredients
have to be investigated,
|
 |
a biopharmaceutical rationale for the pharmaceutical formulation has to be developed and
|
 |
the needs and expectations of the patient population have to be defined.
|